| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |